Warning! GuruFocus detected
1 Severe warning sign
with IMMP.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Current and historical daily PE Ratio for IMMP (
Immutep Ltd
) from 1990 to Apr 28 2025. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Immutep stock (IMMP) PE ratio as of Apr 28 2025 is 9999.
More Details
Immutep Ltd (IMMP) PE Ratio (TTM) Chart
Immutep Ltd (IMMP) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 0
- 1
| Immutep PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Immutep Ltd (IMMP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Immutep Ltd
NAICS : 325412
SIC : 2834
ISIN : US45257L1089
Share Class Description:
IMMP: ADRDescription
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers